Dosing information on CJC 1295

CJC-1295 is typically taken once or twice per week because its effects on growth hormone and IGF-1 can last several days. 1

• Prolonged activity: A drug-affinity complex makes CJC-1295 long-lasting, so it may require fewer injections than daily dosing. 2
• Cardiovascular risks: A death associated with cardiovascular dysfunction occurred in a clinical trial; fluid retention and increased fluid volume were suggested as possible contributing factors, but the connection was uncertain. 3
• FDA-approved alternatives: Sermorelin and tesamorelin were identified as FDA-approved alternatives. 4